Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp)

Molecular Genetics and Metabolism

Volumn 109, Issue 4, 2013, Pages 386-389

  Kawagoe, Shiho ^a   Higuchi, Takashi ^a   Otaka, Manami ^c   Shimada, Yohta ^a   Kobayashi, Hiroshi ^a   Ida, Hiroyuki ^a   Ohashi, Toya ^a   Okano, Hirotaka J ^a   Nakanishi, Mahito ^c   Eto, Yoshikatsu ^a,b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Institute of Neurological Disorders   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Fabry disease; IPS cells; Sendai virus vector; Ultrastructure

Indexed keywords

ALKALINE PHOSPHATASE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NUCLEOCAPSID PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; FABRY DISEASE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LYSOSOME; NERVE CELL; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENDAI VIRUS; SKIN FIBROBLAST; CELL LINE; FIBROBLAST; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; PATHOLOGY; SKIN;

IPS; SENDAI VIRUS;

CELL DIFFERENTIATION; CELL LINE; FABRY DISEASE; FIBROBLASTS; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURONS; SENDAI VIRUS; SKIN; TRANSDUCTION, GENETIC;

EID: 84880796788     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.06.003     Document Type: Article

References (9)

1. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
2. Nishimura K., Sano M., Ohtaka M., Furuta B., Umemura Y., Nakajima Y., Ikehara Y., Kobayashi T., Segawa H., Takayasu S., Sato H., Motomura K., Uchida E., Kanayasu-Toyoda T., Asashima M., Nakauchi H., Yamaguchi T., Nakanishi M. J. Biol. Chem. 2011, 286:4760-4771.
3. Meng X.L., Shen J.S., Kawagoe S., Ohashi T., Brady R.O., Eto Y. Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders. PNAS 2010, 107:7886-7891.
4. Kawagoe S., Higuchi T., Meng X.L., Shimada Y., Shimizu H., Hirayama R., Fukuda T., Chang H., Nakahata T., Fukada S., Ida H., Kobayashi H., Ohashi T., Eto Y. Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells. Mol. Genet. Metab. 2011, 104(1-2):123-128.
5. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
6. Ebert A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., Svendsen C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
7. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
8. Carvajal-Vergara X., Sevilla A., D'Souza S.L., Ang Y.S., Schaniel C., Lee D.F., Yang L., Kaplan A.D., Adler E.D., Rozov R., et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010, 465:808-812.
9. Tolar J., Park I.H., Xia L., Lees C.J., Peacock B., Webber B., McElmurry R.T., Eide C.R., Orchard P.J., Kyba M., et al. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). Blood 2011, 117:839-847.